This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,404.08 firm fixed-price contract is for the delivery of Phenobarbital 130 mg/ml vials. The contract has an ultimate completion date of June 10, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide 65 mg/ml vials of the drug Phenobarbital. The $1,008.66 fixed-price contract has a completion date of February 13, 2025. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the company to supply a wide range of pharmaceutical products and medical supplies to support...
This is a federal contract award by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,561.94 firm-fixed-price delivery order is for the supply of 130 mg/mL vials of the drug Phenobarbital. The contract has an ultimate completion date of June 5, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Phenobarbital 130 mg/ml vials, a medication used for various medical conditions. The contract has a firm fixed price of $5,283.68 and a performance period ending on May 12, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Phenobarbital 130 mg/ml vials to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,417.38 firm fixed price delivery order (SPE2DB24FL2NU) has an ultimate completion date of August 16, 2024 and is not designated as a set-aside. AmerisourceBergen also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Phenobarbital 130 mg/mL vials. The order has a ceiling value of $1,244.41 and is a firm fixed-price contract with a performance period ending on July 30, 2024. This order is not associated with a set-aside program. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies,...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,527.12 firm fixed-price contract is for the delivery of various pharmaceutical products and medical supplies to support military healthcare programs. The contract is not set aside and was competitively awarded. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,938.32 fixed-price delivery order is for the supply of Phenobarbital 130 mg/mL vials. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide PHENOBARBITAL 65 MG/ML VIALML, a pharmaceutical product, with a potential value of $1,334.21. The contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not a set-aside contract. This delivery order is issued under an Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a major procurement arm of the U.S. Department of Defense, to AmerisourceBergen Drug Corp, a prominent pharmaceutical distributor. The $1,497.18 firm-fixed-price contract is for the delivery of various pharmaceutical and medical products, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and specialty pharmaceuticals. The contract is not set aside and is an...